CPIX - Cumberland Pharmaceuticals Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
7.10
+0.07 (+1.00%)
At close: 3:59PM EST
Stock chart is not supported by your current browser
Previous Close7.03
Open7.03
Bid0.00 x 0
Ask0.00 x 0
Day's Range7.01 - 7.11
52 Week Range5.28 - 7.96
Volume6,463
Avg. Volume11,516
Market Cap111.812M
Beta0.54
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • American City Business Journals25 days ago

    The fastest-growing Nashville health care company of 2017 might surprise you

    Nashville is well known for the collection of health care providers that call Music City home. Cumberland Pharmaceuticals Inc. (CPIX), a specialty pharmaceutical company founded in 1999, has seen its stock price rise more than 33 percent to $7.35, and as high as 44 percent, since the beginning of the year. Community Healthcare Trust Inc.’s stock price has risen second-fastest at almost 22 percent, as of today.

  • Is Cumberland Pharmaceuticals Inc (NASDAQ:CPIX) Excessively Paying Its CEO?
    Simply Wall St.25 days ago

    Is Cumberland Pharmaceuticals Inc (NASDAQ:CPIX) Excessively Paying Its CEO?

    A. Kazimi took the helm as Cumberland Pharmaceuticals Inc’s (NASDAQ:CPIX) CEO and grew market cap to $116.38M recently. Understanding how CEOs are incentivised to run and grow their company isRead More...

  • Who Owns Cumberland Pharmaceuticals Inc (NASDAQ:CPIX)?
    Simply Wall St.last month

    Who Owns Cumberland Pharmaceuticals Inc (NASDAQ:CPIX)?

    In this article, I’m going to take a look at Cumberland Pharmaceuticals Inc’s (NASDAQ:CPIX) latest ownership structure, a non-fundamental factor which is important, but remains a less discussed subject amongRead More...

  • Cumberland Pharmaceuticals Inc (CPIX): How Much Growth Is Left In Healthcare?
    Simply Wall St.2 months ago

    Cumberland Pharmaceuticals Inc (CPIX): How Much Growth Is Left In Healthcare?

    Cumberland Pharmaceuticals Inc (NASDAQ:CPIX), a USD$125.35M small-cap, operates in the healthcare industry, which faces key trends such as rising demand fuelled by an aging population and the growing prevalence ofRead More...

  • Capital Cube2 months ago

    ETFs with exposure to Cumberland Pharmaceuticals, Inc. : November 14, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cumberland Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to CPIX-US. Comparing the performance and risk of Cumberland Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of CPIX earnings conference call or presentation 7-Nov-17 9:30pm GMT

    Q3 2017 Cumberland Pharmaceuticals Inc Earnings Call

  • Cumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: Q3, 2017 By the Numbers : November 13, 2017
    Capital Cube2 months ago

    Cumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: Q3, 2017 By the Numbers : November 13, 2017

    Categories: Yahoo FinanceGet free summary analysis Cumberland Pharmaceuticals, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Cumberland Pharmaceuticals, Inc. – Ironwood Pharmaceuticals, Inc. Class A, Pernix Therapeutics Holdings, Inc., DURECT Corporation, Akorn, Inc., Merck & Co., Inc., Mylan N.V., Sucampo Pharmaceuticals, Inc. Class A ... Read more (Read more...)

  • Associated Press2 months ago

    Cumberland reports 3Q loss

    On a per-share basis, the Nashville, Tennessee-based company said it had a loss of 5 cents. Earnings, adjusted for non-recurring costs and stock option expense, were 1 cent per share. The pharmaceutical ...

  • Should You Be Holding Cumberland Pharmaceuticals Inc (CPIX) Right Now?
    Simply Wall St.3 months ago

    Should You Be Holding Cumberland Pharmaceuticals Inc (CPIX) Right Now?

    If you are a shareholder in Cumberland Pharmaceuticals Inc’s (NASDAQ:CPIX), or are thinking about investing in the company, knowing how it contributes to the risk and reward profile of yourRead More...

  • Capital Cube3 months ago

    ETFs with exposure to Cumberland Pharmaceuticals, Inc. : October 25, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cumberland Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to CPIX-US. Comparing the performance and risk of Cumberland Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Cumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017
    Capital Cube3 months ago

    Cumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017

    Categories: Yahoo FinanceGet free summary analysis Cumberland Pharmaceuticals, Inc. reports financial results for the quarter ended June 30, 2017. Highlights Summary numbers: Revenues of USD 8.67 million, Net Earnings of USD -5.16 million. Gross margins narrowed from 76.47% to 73.21% compared to the same period last year, operating (EBITDA) margins now -11.86% from 6.53%. Change in operating ... Read more (Read more...)

  • What Are The Drivers Of Cumberland Pharmaceuticals Inc’s (CPIX) Risks?
    Simply Wall St.4 months ago

    What Are The Drivers Of Cumberland Pharmaceuticals Inc’s (CPIX) Risks?

    If you are a shareholder in Cumberland Pharmaceuticals Inc’s (NASDAQ:CPIX), or are thinking about investing in the company, knowing how it contributes to the risk and reward profile of yourRead More...

  • Thomson Reuters StreetEvents5 months ago

    Edited Transcript of CPIX earnings conference call or presentation 8-Aug-17 8:30pm GMT

    Q2 2017 Cumberland Pharmaceuticals Inc Earnings Call

  • Associated Press5 months ago

    Cumberland reports 2Q loss

    On a per-share basis, the Nashville, Tennessee-based company said it had a loss of 32 cents. Losses, adjusted for pretax expenses and non-recurring costs, were 5 cents per share. The pharmaceutical company ...

  • Capital Cube6 months ago

    ETFs with exposure to Cumberland Pharmaceuticals, Inc. : July 12, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cumberland Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to CPIX-US. Comparing the performance and risk of Cumberland Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube8 months ago

    ETFs with exposure to Cumberland Pharmaceuticals, Inc. : May 25, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cumberland Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to CPIX-US. Comparing the performance and risk of Cumberland Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Cumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 24, 2017
    Capital Cube8 months ago

    Cumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 24, 2017

    Categories: Yahoo FinanceGet free summary analysis Cumberland Pharmaceuticals, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Cumberland Pharmaceuticals, Inc. – Ironwood Pharmaceuticals, Inc. Class A, Pernix Therapeutics Holdings, Inc., DURECT Corporation, Mylan N.V., Merck & Co., Inc., Akorn, Inc., Pfizer Inc. and Sucampo Pharmaceuticals, ... Read more (Read more...)

  • Thomson Reuters StreetEvents8 months ago

    Edited Transcript of CPIX earnings conference call or presentation 15-May-17 8:30pm GMT

    Q1 2017 Cumberland Pharmaceuticals Inc Earnings Call

  • Associated Press8 months ago

    Cumberland reports 1Q loss

    The Nashville, Tennessee-based company said it had a loss of 8 cents per share. Earnings, adjusted for non-recurring costs and stock option expense, came to 2 cents per share. The pharmaceutical company ...

  • Cumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017
    Capital Cube10 months ago

    Cumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017

    Categories: Yahoo Finance Get free summary analysis Cumberland Pharmaceuticals, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Cumberland Pharmaceuticals, Inc. – Ironwood Pharmaceuticals, Inc. Class A, DURECT Corporation, Mylan N.V., Merck & Co., Inc., Akorn, Inc., Pfizer Inc. and Sucampo Pharmaceuticals, Inc. Class A (IRWD-US, ... Read more (Read more...)

  • Cumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017
    Capital Cube10 months ago

    Cumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017

    Categories: Yahoo Finance Get free summary analysis Cumberland Pharmaceuticals, Inc. reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of Cumberland Pharmaceuticals, Inc. – Ironwood Pharmaceuticals, Inc. Class A, Akorn, Inc., Merck & Co., Inc., Mylan N.V., Sucampo Pharmaceuticals, Inc. Class A and Pfizer Inc. (IRWD-US, AKRX-US, MRK-US, ... Read more (Read more...)

  • Thomson Reuters StreetEvents10 months ago

    Edited Transcript of CPIX earnings conference call or presentation 7-Mar-17 9:30pm GMT

    Q4 2016 Cumberland Pharmaceuticals Inc Earnings Call

  • Associated Press10 months ago

    Cumberland reports 4Q loss

    On a per-share basis, the Nashville, Tennessee-based company said it had a loss of 5 cents. Earnings, adjusted for non-recurring costs and stock option expense, were 7 cents per share. The pharmaceutical ...